Resident cardiac mast cells and the cardioprotective effect of ischemic preconditioning in isolated rat heart

Journal of Cardiovascular Pharmacology

Volumn 30, Issue 2, 1997, Pages 149-156

  Parikh, V ^a   Singh, M ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

Cardioprotection; Ischemic preconditioning; Mast cell peroxidase (MPO); Mast cells

Indexed keywords

COMPOUND 48-80; CREATINE KINASE; LACTATE DEHYDROGENASE; PEROXIDASE;

ANIMAL CELL; ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; ISOLATED HEART; MAST CELL; MAST CELL DEGRANULATION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; ARRHYTHMIA; CELL DEGRANULATION; ELECTROCARDIOGRAPHY; FEMALE; HEART; ISCHEMIC PRECONDITIONING, MYOCARDIAL; L-LACTATE DEHYDROGENASE; MAST CELLS; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; P-METHOXY-N-METHYLPHENETHYLAMINE; RATS; RATS, WISTAR;

EID: 0030814902     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199708000-00001     Document Type: Article

References (31)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischaemia: a delay of lethal cell injury in ischaemic myocardium. Circulation 1986;74:1124-36.
2. Pollak OJ. Mast cells in the circulatory system of man. Circulation 1975;16:1084-9.
3. Rydsynski K, Dalen H, Saetersdal T, Engedal H. Morphologic and morphometric analysis of mast cells in the human heart biopsies. Agents Actions 1987;20:288-9.
4. Forman MB, Oates JA, Robertson D, Robertson RM. Roberts LJ, Virmani R. Increased adventitial mast cells in a patient with coronary spasm. N Engl J Med 1985;313:1138-41.
5. Kalsner S, Richards R. Coronary arteries of cardiac patients are hyperreactive and contain stores of amines: a mechanism for coronary spasm. Science 1984;223:1435-7.
6. Keller AM, Clancy RM, Barr ML, Marbee CC, Cannon PJ. Acute reoxygenation injury in isolated rat heart: role of resident cardiac mast cells. Circ Res 1988;63:1044-52.
7. Garland LG, Payne AN. The role of cell fixed calcium in histamine release by compound 48/80. Br J Pharmacol 1979;65:609-13.
8. Paton WDM. Compound 48/80: a potent histamine liberator. Br J Pharmacol 1951;6:499-508.
9. Lagunoff D, Martin TW. Agents that release histamine from mast cells. Annu Rev Pharmacol Toxicol 1983;23:331-51.
10. Babe KS, Serafin WE. Histamine, bradykinin and their antagonists. In: Molunoff PB, Ruddon RW, eds. Goodman and Gilman's The pharmacological basic of therapeutics. New York: Macmillan, 1996:581-600.
11. 3 receptors: pharmacological properties, species differences and receptors functions. Trends Pharmacol Sci 1994;15:298-306.
12. Parratt JR. Possibilities for the pharmacological exploitation of ischaemic preconditioning. J Mol Cell Cardiol 1995;27:991-1000.
13. Langendorff O. Untersuchungen am uberlebender saugethierherzen. Pflugers Archiv Gesmate Physiol Tiere 1895;61:291-332.
14. Hughes BP. A method for the estimation of serum creatine kinase and aldose activity in the normal and pathological sera. Clin Chim Acta 1961;7:597-603.
15. King J. A routine method for the estimation of lactic dehydrogenase activity. J Med Lab Tech 1959;16:265-72.
16. Walker MJA, Curls MJ, Hearse DJ, et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction and reperfusion. Cardiovasc Res 1988;22:447-55.
17. Fralix TA, Steenbergen C, London RE, Murphy E. Glibenclamide does not abolish the protective effect of preconditioning on stunning in the isolated perfused rat heart. Cardiovasc Res 1993;27:630-7.
18. Spieckermann PG, Nordbeck H, Precusse CJ. From heart to plasma. In: Hearse DJ, Leisis JD, eds. Enzymes in cardiology: diagnosis and research. New York: John Wiley, 1978:81-95.
19. Omar BA, Hanson AK, Bose SK, McCord JM. Reperfusion with pyruvate eliminates ischaemic preconditioning in the isolated rabbit heart: an apparent role for enhanced glycolysis. Coron Artery Dis 1991;2:799-804.
20. Ganole CE, Humphrey SM. Effect of anoxic or oxygenated reperfusion in globally ischaemic, isovolumic perfused hearts. Am J Pathol 1985;120:129-45.
21. Ganote CE, Seabra-Gomes R, Nayler WG, Jennings RB. Irreversible myocardial injury in anoxic perfused rat hearts. Am J Pathol 1975;80:419-50.
22. Hearse DJ, Humohrey SM, Bullock GR. The oxygen paradox and calcium paradox: two facets of the same problem? J Mol Cell Cardiol 1978;10:641-68.
23. Grover GJ, Dzwonczyk S, Sleph PG, Sargent CA. The ATP-sensitive potassium channel blocker glybenclamide (glyburide) does not abolish preconditioning in isolated ischaemic rat hearts. J Pharmacol Exp Ther 1993;265:559-64.
24. Steenbergen C, Perlman ME, London RE, Murphy E. Mechanism of preconditioning: ionic alterations. Circ Res 1993;72:112-25.
25. Hendeson WR, Kaliner M. Mast cell granule peroxidase: location, secretion and SRS-A activation. J Immunol 1979;122:1322-8.
26. Austen KF. The heterogeneity of mast cell populations and products. Hosp Pract 1984;19:135-46.
27. Ito BR, Engler RL, DelBalzo U. Role of cardiac mast cells in complement C-5a induced myocardial ischaemia. Am J Physiol 1993;264:H1346-54.
28. Schwartz LB, Austen KF. Structure and function of chemical mediators of mast cells. Prog Allergy 1984;34:271-321.
29. van Haaster CMCJ, Engels W, Duijvestijn AM, Lemmens PJMR, Hornstra G, Van der Vusse GJ. Lack of evidence for a role of mast cell degranulation in acute hypoxia/reoxygenation-induced injury in the isolated rat heart. J Mol Cell Cardiol 1996;28:363-73.
30. Wolff AA, Levi R. Ventricular arrhythmias parallel cardiac histamine efflux after coronary artery occlusion in the dog. Agents Actions 1988;25:296-306.
31. Li Y, Whittaker P, Kloner RA. The transient nature of the effect of ischaemic preconditioning on myocardial infarct size and ventricular arrhythmia. Am Heart J 1992;123:346-53.